-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

News|Articles|June 28, 2024

How Well Do You Know the June 2024 Issue of AJMC?

Author(s)Julia Bonavitacola

Test your knowledge of the June 2024 issue of AJMC with this quick quiz!

True or False: A high cadence of primary care visits was able to significantly reduce hospitalizations in high-risk patients.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Kerry Rogers, MD, The James

Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL

ByMaggie L. Shaw,Kerry Rogers, MD

July 11th 2026

4 Dice that spell out "FDA Approved" surrounded by pills on a table. | Image Credit: Frank H.-stock.adobe.com.jpeg

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer

ByElla Hohmann, MS

July 10th 2026

Parasite | Image credit: @ecrow_AdobeStock.jpeg

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

BySabrina McCrear

July 10th 2026

AI text with icons floating above it. | Image Credit: Zenzeta-stock.adobe.com.jpeg

AI Chatbots Score Below 28% on Colorectal Cancer Questions

ByElla Hohmann, MS

July 10th 2026

Woman stands on the scales. Measuring tape. Weight loss - Atlas - stock.adobe.com

Setmelanotide Cuts BMI, Hunger in Phase 3 Trial for Hypothalamic Obesity

ByGiuliana Grossi

July 10th 2026

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

INCA033989 May Address Unmet Need in Mutant Calreticulin Myelofibrosis: Claire Harrison, MD

Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer